Market Updates Atherectomy Devices Market Revenue Status 2021 | Page 3

Reduction of abdominal obesity through lifestyle measures can improve all components of the metabolic syndrome and likely delay the development of both diabetes and atherosclerosis. Beyond lifestyle intervention, optimal management of risk factors to evidence-based targets is essential. High awareness of health problems caused due to change in lifestyle and optimal management of risk factors can improve the metabolic syndrome and likely reduce the development of both diabetes and atherosclerosis and hence reducing the demand for the atherectomy devices. The major companies of the Atherectomy Devices Market include Bayer AG, Cardiovascular systems, St. Jude medica, Boston scientific corporation, Abbott laboratories, C.R Bard Inc., Volcano Corporation. The competition in this Atherectomy Devices Market usually depends on the technology used in manufacturing of the devices and also the pricing strategies. Medtronic’s is leading competitor in peripheral atherectomy devices. Medtronic acquired Covedian in 2015 and is expected to remain in the leading position however it will face increasing competition from cardiovascular systems Inc. Market Segment: This report studies Atherectomy Devices in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering • Boston Scientific • Cardiovascular Systems • Medtronic • Spectranetics • Other prominent vendors • Avinger • Volcano See More Reports of This Category by Million Insights @ https://www.millioninsights.com/industry/medical-devices Market Segment by Regions, this report splits Global into several key Region, with production, consumption, revenue, market share and growth rate of Atherectomy Devices in these regions, from 2011 to 2021 (forecast), like • North America • China